Neko Health Raises $700M to Expand AI Body Scans in US
Preventive healthcare startup backed by Daniel Ek targets rapid clinic rollout across major American cities.
Preventive healthcare pioneer Neko Health has closed a monumental $700 million Series B funding round to launch its advanced AI-powered full-body scanning technology in the United States. Founded by Spotify creator Daniel Ek and Hjalmar Nilsonne, the Swedish startup aims to transition medicine from reactive symptom management to proactive early detection. This massive capital injection represents one of the largest healthtech investments of 2026, signaling immense market confidence in AI-driven diagnostic medicine.
Key Details
The oversubscribed $700 million funding round was co-led by major global venture capital firms, including existing investors and prominent American healthtech funds. Neko Health plans to use the capital to establish state-of-the-art preventive scanning clinics in ten major metropolitan areas across the United States over the next eighteen months, starting with flagship locations in New York, Los Angeles, and San Francisco.
Additionally, the funds will go toward scaling their proprietary cloud infrastructure and further refining their multi-modal machine learning models. Since its European launch, Neko Health has scanned tens of thousands of individuals, discovering early-stage cardiovascular anomalies, metabolic risks, and skin abnormalities in patients who were otherwise entirely asymptomatic. The expansion will make proactive diagnostic technology accessible to the broader American consumer market for the first time.
What This Means
For decades, the modern medical establishment has operated on a reactive paradigm—treating chronic conditions and life-threatening illnesses only after symptoms manifest. By then, interventions are often incredibly expensive and far less effective. Neko Health's model flips this dynamic on its head by utilizing non-invasive sensor fusion to identify microscopic physiological changes before they escalate into clinical symptoms.
In a healthcare environment like the United States, plagued by soaring chronic disease rates and staggering administrative overhead, a shift toward highly automated, preventive diagnostic tracking could dramatically reduce the overall burden on hospitals and public resources. It represents a fundamental democratization of clinical-grade imaging, putting powerful, actionable data directly into the hands of consumers.
Technical Breakdown
The core of Neko Health’s platform is an futuristic, custom-built scanning cabin equipped with over 70 high-resolution sensors and advanced imaging devices. In a single 10-minute scan, the cabin collects over 50 million data points across a variety of physiological systems:
- Full-Body 3D Optical Reconstruction: Uses multi-spectral cameras to build an extremely detailed 3D model of the patient's skin, tracking mole changes, dermatological lesions, and vascular patterns with sub-millimeter accuracy.
- Cardiovascular and Hemodynamic Analysis: Integrates advanced radar, photoplethysmography, and electrocardiogram sensors to evaluate arterial stiffness, pulse wave velocity, and cardiac rhythm anomalies.
- Thermal and Metabolic Imaging: Deploys high-sensitivity thermal imaging to detect localized inflammation, circulatory issues, and micro-vascular irregularities that could indicate early-stage metabolic disorders.
These raw data points are continuously processed by Neko’s proprietary multi-modal neural networks. These models analyze the sensor fusion data in real-time, benchmarking individual physiological profiles against a rapidly expanding, anonymized clinical dataset to flag even the most subtle deviations from a healthy baseline.
Industry Impact
This massive fundraise will undoubtedly send shockwaves through the healthcare and insurance sectors. Traditional insurers have historically hesitated to cover broad preventive screenings due to high costs and the risk of false positives. However, Neko Health's extremely low cost of operation, driven by extensive AI automation, could force insurers to rethink their preventive care incentives.
Furthermore, Neko’s aggressive entry into the US market presents a direct challenge to traditional diagnostic imaging firms and boutique concierge medicine providers. By offering an integrated, consumer-friendly, and cost-effective screening experience, Neko is positioning itself as the foundational platform for a new, consumer-led era of digital health maintenance.
Looking Ahead
As Neko Health begins its rollout in New York and California, the company is also looking to expand its strategic integrations. Plans are underway to establish partnerships with local health systems and primary care networks, allowing patients to seamlessly share their automated reports with their own physicians.
The long-term vision is not just a network of cabins, but a persistent, personalized longitudinal health record for every user. By tracking physiological metrics continuously over years, Neko's AI will soon be capable of predicting personal disease trajectories long before they happen, realizing the ultimate promise of machine intelligence in biology.
Source: AI News(opens in a new tab) Published on ShtefAI blog by Shtef ⚡
